Psychosis is a common symptom of Parkinson's disease. More than half of all patients will eventually develop some symptoms. We're not sure of the exact cause. But chemicals in the brain ...

Psychosis and visual hallucinations are one of the most common non-motor aspects of Parkinson's disease (PD), affecting up to 40% of individuals with PD. Psychosis in PD commonly starts as minor ...

In my teeter totter example, too little Dopamine results in Parkinson’s type movement disorders and too much Dopamine results in psychosis and addiction. Treatment of Parkinson’s disease ...

and judging distances are estimated to occur in 40 percent or more of people with Parkinson's. Psychosis and hallucinations ...

Novel antipsychotics, such as ziprasidone and aripiprazole, in the treatment of psychosis in PD remain controversial. Cholinesterase inhibitors are useful, especially in the presence of cognitive ...

GOTHENBURG, SE / ACCESS Newswire / March 12, 2025 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Gothenburg, March 12, 2025 - ...

Nuplazid (pimavanserin) is already FDA-approved to treat psychosis caused by Parkinson's disease, but Acadia's hope to expanding that use to the Alzheimer's population were shot down by a complete ...

Parkinson's disease is an illness that affects the part of your brain that controls how you move your body. Some people with Parkinson’s first notice weakness, difficulty walking, and stiff muscles.

Hospice use varies depending on whether a person has Parkinson’s disease, Lewy body dementia or Alzheimer’s disease and those with Parkinson’s may have more unmet needs, a new study finds.

George Demos, 64, formerly of Acadia Pharmaceuticals Inc., admitted selling more than 60,000 company shares just before news broke regarding an issue with one of the company's products ...

GOTHENBURG, SE / ACCESS Newswire / March 12, 2025 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Gothenburg, March 12, 2025 - IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a company discovering and ...